These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8845307

  • 41. Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells.
    Azuma-Hara M, Taniura H, Uetsuki T, Niinobe M, Yoshikawa K.
    Exp Cell Res; 1999 Sep 15; 251(2):442-51. PubMed ID: 10471329
    [Abstract] [Full Text] [Related]

  • 42. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB.
    Science; 1995 Feb 17; 267(5200):1018-21. PubMed ID: 7863327
    [Abstract] [Full Text] [Related]

  • 43. A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription.
    Gartel AL, Najmabadi F, Goufman E, Tyner AL.
    Oncogene; 2000 Feb 17; 19(7):961-4. PubMed ID: 10702805
    [Abstract] [Full Text] [Related]

  • 44. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.
    Rosenthal SM, Cheng ZQ.
    Proc Natl Acad Sci U S A; 1995 Oct 24; 92(22):10307-11. PubMed ID: 7479773
    [Abstract] [Full Text] [Related]

  • 45. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms.
    Tiainen M, Spitkovsky D, Jansen-Dürr P, Sacchi A, Crescenzi M.
    Mol Cell Biol; 1996 Oct 24; 16(10):5302-12. PubMed ID: 8816442
    [Abstract] [Full Text] [Related]

  • 46. Expression of a PKR dominant-negative mutant in myogenic cells interferes with the myogenic process.
    Salzberg S, Vilchik S, Cohen S, Heller A, Kronfeld-Kinar Y.
    Exp Cell Res; 2000 Jan 10; 254(1):45-54. PubMed ID: 10623464
    [Abstract] [Full Text] [Related]

  • 47. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
    Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ.
    Oncogene; 1989 Apr 10; 4(4):473-81. PubMed ID: 2654809
    [Abstract] [Full Text] [Related]

  • 48. Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation.
    Sakai H, Murakami C, Matsumoto KI, Urano T, Sakane F.
    Biochimie; 2018 Aug 10; 151():45-53. PubMed ID: 29859210
    [Abstract] [Full Text] [Related]

  • 49. Developmental pattern of expression of NPDC-1 and its interaction with E2F-1 suggest a role in the control of proliferation and differentiation of neural cells.
    Dupont E, Sansal I, Evrard C, Rouget P.
    J Neurosci Res; 1998 Jan 15; 51(2):257-67. PubMed ID: 9469579
    [Abstract] [Full Text] [Related]

  • 50. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.
    Sumitani S, Goya K, Testa JR, Kouhara H, Kasayama S.
    Endocrinology; 2002 Mar 15; 143(3):820-8. PubMed ID: 11861503
    [Abstract] [Full Text] [Related]

  • 51. Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts.
    Evangelisti C, Tazzari PL, Riccio M, Fiume R, Hozumi Y, Falà F, Goto K, Manzoli L, Cocco L, Martelli AM.
    FASEB J; 2007 Oct 15; 21(12):3297-307. PubMed ID: 17488950
    [Abstract] [Full Text] [Related]

  • 52. Constitutive expression of the E2F1 transcription factor in fibroblasts alters G0 and S phase transit following serum stimulation.
    Logan TJ, Jordan KL, Hall DJ.
    Biochem Cell Biol; 1996 Oct 15; 74(1):21-8. PubMed ID: 9035687
    [Abstract] [Full Text] [Related]

  • 53. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
    Farra R, Dapas B, Pozzato G, Scaggiante B, Agostini F, Zennaro C, Grassi M, Rosso N, Giansante C, Fiotti N, Grassi G.
    Dig Liver Dis; 2011 Dec 15; 43(12):1006-14. PubMed ID: 21831731
    [Abstract] [Full Text] [Related]

  • 54. The paradox of E2F1: oncogene and tumor suppressor gene.
    Johnson DG.
    Mol Carcinog; 2000 Mar 15; 27(3):151-7. PubMed ID: 10708476
    [Abstract] [Full Text] [Related]

  • 55. The transcription factor E2F1 modulates apoptosis of neurons.
    Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, Morley P, Murray C, Rasquinha I, Slack R, MacManus JP.
    J Neurochem; 2000 Jul 15; 75(1):91-100. PubMed ID: 10854251
    [Abstract] [Full Text] [Related]

  • 56. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation.
    Rao SS, Kohtz DS.
    J Biol Chem; 1995 Feb 24; 270(8):4093-100. PubMed ID: 7876159
    [Abstract] [Full Text] [Related]

  • 57. Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor.
    Logan TJ, Jordan KL, Hall D.
    Mol Biol Cell; 1994 Jun 24; 5(6):667-78. PubMed ID: 7949423
    [Abstract] [Full Text] [Related]

  • 58. Genome-wide examination of myoblast cell cycle withdrawal during differentiation.
    Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, Bernstein HS.
    Dev Dyn; 2003 Jan 24; 226(1):128-38. PubMed ID: 12508234
    [Abstract] [Full Text] [Related]

  • 59. No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice.
    Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, Harlow E, Yamasaki L, Farnham PJ.
    Mol Carcinog; 1999 Aug 24; 25(4):295-303. PubMed ID: 10449036
    [Abstract] [Full Text] [Related]

  • 60. Overexpression of chemokine-like factor 2 promotes the proliferation and survival of C2C12 skeletal muscle cells.
    Xia D, Li X, Lou Y, Han W, Ding P, Zhang Y, Di C, Song Q, Ma D.
    Biochim Biophys Acta; 2002 Aug 19; 1591(1-3):163-173. PubMed ID: 12183067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.